Application 212640
- Type
- NDA
- Sponsor
- AQUESTIVE THERAP
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | EXSERVAN | RILUZOLE | FILM;ORAL | 50MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N212640-001 | EXSERVAN | RILUZOLE | 50MG | FILM / ORAL | RLD | 2019-11-22 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD | 2019-11-22 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD | 2019-11-22 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD | 2019-11-22 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD | 2019-11-22 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD | 2019-11-22 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD | 2019-11-22 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD | 2019-11-22 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD | 2019-11-22 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD | 2019-11-22 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | 4b0b4de00fa7… | |
| 2022-03-09 01:35 UTC | 2022-03 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | 3f01610625f2… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD, RS | 2019-11-22 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N212640-001 | EXSERVAN | 50MG | FILM / ORAL | RLD | 2019-11-22 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212640-001 | 8765167 | 2024-02-20 | Drug product | 2020-06-02 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212640-001 | 8603514 | 2024-04-03 | Drug product | 2020-06-02 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212640-001 | 8765167 | 2024-02-20 | Drug product | 2020-06-02 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212640-001 | 8603514 | 2024-04-03 | Drug product | 2020-06-02 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212640-001 | 8765167 | 2024-02-20 | Drug product | 2020-06-02 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212640-001 | 8603514 | 2024-04-03 | Drug product | 2020-06-02 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212640-001 | 8765167 | 2024-02-20 | Drug product | 2020-06-02 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212640-001 | 8603514 | 2024-04-03 | Drug product | 2020-06-02 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N212640-001 | 8765167 | 2024-02-20 | Drug product | 2020-06-02 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N212640-001 | 8603514 | 2024-04-03 | Drug product | 2020-06-02 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212640-001 | 8765167 | 2024-02-20 | Drug product | 2020-06-02 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212640-001 | 8603514 | 2024-04-03 | Drug product | 2020-06-02 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N212640-001 | 8765167 | 2024-02-20 | Drug product | 2020-06-02 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N212640-001 | 8603514 | 2024-04-03 | Drug product | 2020-06-02 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N212640-001 | 8765167 | 2024-02-20 | Drug product | 2020-06-02 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N212640-001 | 8603514 | 2024-04-03 | Drug product | 2020-06-02 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N212640-001 | 8765167 | 2024-02-20 | Drug product | 2020-06-02 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N212640-001 | 8603514 | 2024-04-03 | Drug product | 2020-06-02 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N212640-001 | 8765167 | 2024-02-20 | Drug product | 2020-06-02 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N212640-001 | 8603514 | 2024-04-03 | Drug product | 2020-06-02 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N212640-001 | 8765167 | 2024-02-20 | Drug product | 2020-06-02 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N212640-001 | 8603514 | 2024-04-03 | Drug product | 2020-06-02 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N212640-001 | 8765167 | 2024-02-20 | Drug product | 2020-06-02 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N212640-001 | 8603514 | 2024-04-03 | Drug product | 2020-06-02 | 4b0b4de00fa7… | |
| 2022-03-09 01:35 UTC | 2022-03 | N212640-001 | 8765167 | 2024-02-20 | Drug product | 2020-06-02 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N212640-001 | 8603514 | 2024-04-03 | Drug product | 2020-06-02 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N212640-001 | 8765167 | 2024-02-20 | Drug product | 2020-06-02 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N212640-001 | 8603514 | 2024-04-03 | Drug product | 2020-06-02 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N212640-001 | 8765167 | 2024-02-20 | Drug product | 2020-06-02 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N212640-001 | 8603514 | 2024-04-03 | Drug product | 2020-06-02 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N212640-001 | 8765167 | 2024-02-20 | Drug product | 2020-06-02 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | N212640-001 | 8603514 | 2024-04-03 | Drug product | 2020-06-02 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N212640-001 | 8765167 | 2024-02-20 | Drug product | 2020-06-02 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N212640-001 | 8603514 | 2024-04-03 | Drug product | 2020-06-02 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N212640-001 | 8765167 | 2024-02-20 | Drug product | 2020-06-02 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N212640-001 | 8603514 | 2024-04-03 | Drug product | 2020-06-02 | c0c555d07b60… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N212640-001 | 8765167 | 2024-02-20 | Drug product | 2020-06-02 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N212640-001 | 8603514 | 2024-04-03 | Drug product | 2020-06-02 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N212640-001 | 8765167 | 2024-02-20 | Drug product | 2020-06-02 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | N212640-001 | 8603514 | 2024-04-03 | Drug product | 2020-06-02 | 1c564ffb4f44… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TIGLUTIK | RILUZOLE | Italfarmaco SPA | 20b7165a-eb4d-42a0-b2d8-16eff90a214e | 2026-07-29 | RILUZOLE | |
| TIGLUTIK | RILUZOLE | EDW PHARMA, INC | 75d68f19-4208-109e-e053-2991aa0ac857 | 2026-07-27 | Warnings, Adverse reactions | RILUZOLE |
| Riluzole | RILUZOLE | Ascend Laboratories, LLC | dd432c13-389e-46b3-8891-0cf1a58800ff | 2026-07-15 | Warnings, Adverse reactions | RILUZOLE |
| RILUZOLE | RILUZOLE | Florida Pharmaceutical Products, LLC | ccead445-970c-46a1-9532-2848cc2aa3b6 | 2026-04-24 | Warnings, Adverse reactions | RILUZOLE |
| Riluzole | RILUZOLE | AvKARE | b117b981-476c-f9b8-e053-2995a90aee5f | 2026-03-04 | Warnings, Adverse reactions | RILUZOLE |
| Teglutik | RILUZOLE | EDW PHARMA | 1a3aeb59-d589-8d12-e063-6394a90a0a3a | 2025-12-31 | RILUZOLE | |
| Teglutik | RILUZOLE | EDW PHARMA, INC | 0f2b5cfc-a23d-699a-e063-6394a90a67d1 | 2025-12-31 | RILUZOLE | |
| Teglutik | RILUZOLE | EDW PHARMA | 125fdd37-02f7-a610-e063-6294a90a009d | 2025-12-31 | RILUZOLE | |
| riluzole | RILUZOLE | Glenmark Pharmaceuticals Inc., USA | f1ce57e8-d3fe-422c-8724-3101c258898a | 2020-07-10 | Warnings, Adverse reactions | RILUZOLE |
| Riluzole | RILUZOLE | Sun Pharmaceutical Industries, Inc. | 4c851be4-f0d0-4b24-baf9-427ddfc6f7b0 | 2020-05-16 | Warnings, Adverse reactions | RILUZOLE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 10094-350 | EXSERVAN | riluzole | Aquestive Therapeutics | NDA | Current |
| 10094-350 | EXSERVAN | riluzole | Aquestive Therapeutics | NDA | Current |
| 70510-2201 | Exservan | riluzole | Mitsubishi Tanabe Pharma America, Inc. | NDA | Current |
| 70510-2201 | Exservan | riluzole | Mitsubishi Tanabe Pharma America, Inc. | NDA | Current |
| 70510-2201 | Exservan | riluzole | Mitsubishi Tanabe Pharma America, Inc. | NDA | Current |
| 70510-2201 | Exservan | riluzole | Mitsubishi Tanabe Pharma America, Inc. | NDA | Current |
| 70510-2202 | Exservan | riluzole | Mitsubishi Tanabe Pharma America, Inc. | NDA | Current |